This story originally ran on Nov. 11.
By Tony Fong
Discovering protein biomarkers and having them adopted by clinical practitioners are two distinct processes with different criteria.
If clinical proteomics will ever achieve success, proteomics researchers will need to master both processes. That was the take-home from some speakers at a meeting held last week by the American Association of Clinical Chemistry.